Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-02-22
2005-02-22
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S424000, C424S425000, C424S426000, C623S001100, C623S001420
Reexamination Certificate
active
06858221
ABSTRACT:
The present invention provides improved devices and methods for minimizing and/or inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides luminal prostheses which allow for programmed and controlled mycophenolic acid delivery with increased efficacy to selected locations within a patient's vasculature to inhibit restenosis. An intraluminal delivery prosthesis may comprise an expansible structure and means on or within the structure for releasing mycophenolic acid at a rate selected to inhibit smooth muscle cell proliferation.
REFERENCES:
patent: 3705894 (1972-12-01), Gerzan et al.
patent: 3705946 (1972-12-01), Dyke et al.
patent: 3777020 (1973-12-01), Johnson
patent: 3868454 (1975-02-01), Johnson
patent: 3880995 (1975-04-01), Jones
patent: 3903071 (1975-09-01), Holmes
patent: 3976071 (1976-08-01), Sadek
patent: 3993749 (1976-11-01), Sehgal et al.
patent: 4115197 (1978-09-01), Queener et al.
patent: 4234684 (1980-11-01), Abbott et al.
patent: 4335094 (1982-06-01), Mosbach
patent: 4345588 (1982-08-01), Widder et al.
patent: 4357259 (1982-11-01), Wenyei et al.
patent: 4501726 (1985-02-01), Schröder et al.
patent: 4686234 (1987-08-01), Nelson et al.
patent: 4727069 (1988-02-01), Nelson et al.
patent: 4753935 (1988-06-01), Nelson et al.
patent: 4786637 (1988-11-01), Allison et al.
patent: 4810524 (1989-03-01), Nakayama et al.
patent: 4832686 (1989-05-01), Anderson
patent: 4871716 (1989-10-01), Longo et al.
patent: 4883666 (1989-11-01), Sabel et al.
patent: 4894231 (1990-01-01), Mareau et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4904479 (1990-02-01), Illum
patent: 4921723 (1990-05-01), Nichols et al.
patent: 4936281 (1990-06-01), Stasz
patent: 5000185 (1991-03-01), Yock
patent: 5024671 (1991-06-01), Tu et al.
patent: 5067491 (1991-11-01), Taylor, II et al.
patent: 5069216 (1991-12-01), Groman et al.
patent: 5112457 (1992-05-01), Marchant
patent: 5163952 (1992-11-01), Froix
patent: 5176907 (1993-01-01), Leong
patent: 5206159 (1993-04-01), Cohen et al.
patent: 5225282 (1993-07-01), Chagnon et al.
patent: 5283257 (1994-02-01), Gregory et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5342348 (1994-08-01), Kaplan
patent: 5355832 (1994-10-01), Loh et al.
patent: 5356433 (1994-10-01), Rowland et al.
patent: 5368557 (1994-11-01), Nita et al.
patent: 5409000 (1995-04-01), Imran
patent: 5411550 (1995-05-01), Herweck et al.
patent: 5419760 (1995-05-01), Narciso, Jr.
patent: 5447724 (1995-09-01), Helmus et al.
patent: 5447799 (1995-09-01), Loh et al.
patent: 5463010 (1995-10-01), Hu et al.
patent: 5464450 (1995-11-01), Buscemi et al.
patent: 5464650 (1995-11-01), Berg et al.
patent: 5474563 (1995-12-01), Myler et al.
patent: 5484584 (1996-01-01), Wallace et al.
patent: 5500013 (1996-03-01), Buscemi et al.
patent: 5512055 (1996-04-01), Domb et al.
patent: 5516781 (1996-05-01), Morris et al.
patent: 5543158 (1996-08-01), Gref et al.
patent: 5545208 (1996-08-01), Wolff et al.
patent: 5551954 (1996-09-01), Buscemi et al.
patent: 5563146 (1996-10-01), Morris et al.
patent: 5569463 (1996-10-01), Helmus et al.
patent: 5591227 (1997-01-01), Dinh et al.
patent: 5609629 (1997-03-01), Fearnot et al.
patent: 5624411 (1997-04-01), Tuch
patent: 5637113 (1997-06-01), Tartaglia et al.
patent: 5646160 (1997-07-01), Morris et al.
patent: 5649977 (1997-07-01), Campbell
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 5665728 (1997-09-01), Morris et al.
patent: 5679400 (1997-10-01), Tuch
patent: 5700286 (1997-12-01), Tartaglia et al.
patent: 5725494 (1998-03-01), Brisken
patent: 5725567 (1998-03-01), Wolff et al.
patent: 5728062 (1998-03-01), Brisken
patent: 5735811 (1998-04-01), Brisken
patent: 5769883 (1998-06-01), Buscemi et al.
patent: 5769884 (1998-06-01), Solovay
patent: 5807876 (1998-09-01), Armistead et al.
patent: 5824049 (1998-10-01), Ragheb et al.
patent: 5837008 (1998-11-01), Berg et al.
patent: 5843172 (1998-12-01), Yan
patent: 5851231 (1998-12-01), Wolff et al.
patent: 5876452 (1999-03-01), Athanasiou et al.
patent: 5879808 (1999-03-01), Wary et al.
patent: 5891108 (1999-04-01), Leone et al.
patent: 5893840 (1999-04-01), Hull et al.
patent: 5916585 (1999-06-01), Cook et al.
patent: 5928145 (1999-07-01), Ocali et al.
patent: 5951586 (1999-09-01), Berg et al.
patent: 5958510 (1999-09-01), Sivaramakrishnam et al.
patent: 5968092 (1999-10-01), Buscemi et al.
patent: 5972027 (1999-10-01), Johnson
patent: 5980551 (1999-11-01), Summers et al.
patent: 5980566 (1999-11-01), Alt et al.
patent: 5997468 (1999-12-01), Wolff et al.
patent: 6031375 (2000-02-01), Atalar et al.
patent: 6051276 (2000-04-01), Wary et al.
patent: 6054122 (2000-04-01), MacPhae
patent: 6063101 (2000-05-01), Jacobsen et al.
patent: 6071305 (2000-06-01), Brown et al.
patent: 6086952 (2000-07-01), Lang et al.
patent: 6096070 (2000-08-01), Ragheb et al.
patent: 6099561 (2000-08-01), Alt
patent: 6107052 (2000-08-01), Dorn
patent: 6153252 (2000-11-01), Hossainy et al.
patent: 6183507 (2001-02-01), Lashinski et al.
patent: 6197013 (2001-03-01), Reed et al.
patent: 6203536 (2001-03-01), Berg et al.
patent: 6240616 (2001-06-01), Yan
patent: 6253443 (2001-07-01), Johnson
patent: 6273908 (2001-08-01), Ndondo-Lay
patent: 6273913 (2001-08-01), Wright et al.
patent: 6287628 (2001-09-01), Hossainy et al.
patent: 6299604 (2001-10-01), Ragheb et al.
patent: 6395326 (2002-05-01), Castro et al.
patent: 6471980 (2002-10-01), Sirhan et al.
patent: 20010027340 (2001-10-01), Wright et al.
patent: 20010029351 (2001-10-01), Falotico et al.
patent: 20020005206 (2002-01-01), Falotico et al.
patent: 20020007213 (2002-01-01), Falotico et al.
patent: 20020007214 (2002-01-01), Falotico
patent: 20020007215 (2002-01-01), Falotico et al.
patent: 20020016625 (2002-02-01), Falotico et al.
patent: 20020032414 (2002-03-01), Ragheb et al.
patent: 063 365 (1985-09-01), None
patent: 184 162 (1994-04-01), None
patent: 0 923 953 (1999-06-01), None
patent: WO 9013332 (1990-11-01), None
patent: WO 0010622 (2000-03-01), None
patent: WO 0101957 (2001-01-01), None
patent: WO 0141678 (2001-06-01), None
patent: WO0141678 (2001-06-01), None
Epinette et al., “Mycophenolic acid for psoriasis” Journal of the American Academy of Dermatology, 17:962-971 (1987).
Gregory et al., “Effects of treatment with cycloporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and vivo” Transplant Proc., 25:770-771 (1993).
Grinyo et al., “Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevenion of acute rejection” Lancet, pp. 345,:1321-1325 (1995).
Lee et al. Bioavailability improvement of mycophenolic acid through amino ester derivatization Pharmaceutical Research, 2:161-166 (1990).
Mohacsi et al., “Different inhibitory effects of immunosuppresive drugs on hyman and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor” J Heart and Lung Transplant, 16:484-491 (1997).
Nelson et al., “Synthesis and immunosuppressive activity of some side-chain variants mycophenolic acid” Journal of Medicinal Chemistry, 33:833-838 (1990).
Rajasubramanian et al., “Fabrication of resorbable microporus intravascular stents for gene therapy applications,”ASAIO Journal, 40:M584-589 (1994).
U.S. patent application No. 09/782,804, filed Feb. 13, 2001, entitled “Intravascular delivery of methylprednisolone.”
U.S. patent application Ser. No. 09/782,927, filed Feb. 13, 2001, entitled “Intravascular delivery of mycophenolic acid.”
U.S. patent application Ser. No. 09/783,254, filed Feb. 13, 2001, entitled “Intravascular delivery of mizorbine”.
Sirhan Motasim
Yan John
Avantec Vascular Corporation
Azpuru Carlos A.
LandOfFree
Intravascular delivery of mycophenolic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravascular delivery of mycophenolic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravascular delivery of mycophenolic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3510257